Tirzepatide (Mounjaro and Zepbound), semaglutide-based medications such as Wegovy, and other GLP-1based treatments require medical evaluation to determine eligibility, appropriate dosing, and safety
I am telling you because it is the clearest example I have of what diaTribe is for: making sure the patient voice is in the room when the guidance gets written
The initial flare-up of acne breakouts typically peaks around week 2-3 and begins to subside as you enter month two
a more favorable option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS Reference: rxlist.com (Tanzeum) Dulaglutide Drug Name: Trulicity (FDA Approved 9/18/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 5 days) subcutaneous pen injections weekly dosing (vs daily dosing for some other GLP-1 agonists such as exenatide, liraglutide & lixisenatide) a more favorable dosing option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Thus, the above factors are consolidating the region's position as the fastest-growing force in the global glucagon-like peptide 1 (GLP-1) analogues market
Additionally, the medication's effects on gut motility and the gastrointestinal microenvironment have not been extensively studied in the context of active intestinal inflammation
